Therapeutic Innovation Australia (TIA)
Therapeutic Innovation Australia (TIA) is the lead agent for the NCRIS “Therapeutic Innovation Australia” project. TIA a national consortium of translational research infrastructure that provides researchers and SMEs the expertise and capabilities required to move a potential therapeutic product along the development pathway.
National Deuteration Facility (NDF)
ANSTO’s National Deuteration Facility (NDF) is an NCRIS funded program which created and supports Australia’s only molecular deuteration facility. NDF provides access to landmark infrastructure and expertise for chemical and biological deuteration capabilities, facilitating world-leading research for Australian users to address complex challenges in industrial, medical and environmental applications.
EMBL Australia
EMBL Australia is a life science network that supports ambitious research projects and provides access to infrastructure and training to early-career Australian scientists. Through Australia’s associate membership of the European Molecular Biology Laboratory (EMBL), Australian researchers can access EMBL’s broad range of world-class infrastructures and international expertise.
Australian National Fabrication Facility (ANFF)
ANFF owns and provides access to micro and nanofabrication capabilities for Australia’s researchers and industry. We can assist in both the development of new products and improvements to current production methods. Each Node provides expertise in a specific area, including advanced materials, nanoelectronics & photonics and nano-bio applications. The ANFF commitment to providing a world-class, open-access user facility is underpinned by the sharing of best practice in service provision across the network.
